utrition supplementation before and after revascularisation procedure for people with peripheral arterial disease compared to usual care

Not Applicable

• Conditions: Peripheral arterial disease; Revascularisation procedure; Cardiovascular - Other cardiovascular diseases; Diet and Nutrition - Other diet and nutrition disorders; Surgery - Other surgery

• Registration Number: ACTRN12622000360718
• Lead Sponsor: Abbott Medical Australia Pty Ltd

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-03-01
• Last Update Posted: 7 March 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 264

Inclusion Criteria

Inpatients and outpatients at Flinders Medical Centre who are scheduled to undergo open or endovascular revascularisation for PAD.

Exclusion Criteria

Patients will be excluded if they are: 1) <18 years old; 2) have been diagnosed with a terminal illness; 3) are unable to communicate effectively to provide informed consent such as those with cognitive impairment; 4) have a diagnosis of galactosemia (a contra-indication to immuno-nutrition supplement) or 5) have a fluid restriction.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Binary restenosis (restenosis >50%) as determined by duplex ultrasound.[Day 1 post-procedure, 1, 3, 6 and 12 months (primary endpoint) post revascularisation procedure. ]